5 most read GI/endoscopy stories — Dec. 12, 2016

Here are the five most read gastroenterology/endoscopy stories for the week of Dec. 12, 2016.

Advertisement

1. Valeant, Takeda deal crumbles; Valeant to invest in Salix: 6 things to know
Click here

2. Metastatic tumor-destroying vaccine for colon cancer patients to begin phase II trial: 6 key notes
Click here

3. GI societies objects to American Board of Internal Medicine’s certification proposals: 4 notes
Click here

4. How LifeBond is trying to solve a surgeon’s biggest headache
Click here

5. Invendo receives CE Mark for sterile, single-use endoscope: 5 things you need to know
Click here

More articles on gastroenterology/endoscopy:
Dr. Albert Czaja receives Mayo Clinic award & more — 3 GI physicians in the headlines
NCI scientists reverse a woman’s colon cancer with immunotherapy: 5 research insights
GI leader to know: Dr. Kumar Gutta of Gastroenterology Associates of North Texas

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.